Results 31 to 40 of about 19,557 (198)
JACC: Case Reports, 2019 A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy.
Evan C. Klein, MD +2 more
doaj +1 more source
Paediatrics: how to manage septic shock
Drugs in Context, 2021 Background: Septic shock is a common critical illness associated with high morbidity and mortality in children. This article provides an updated narrative review on the management of septic shock in paediatric practice.
Kam Lun Hon +3 more
doaj +1 more source
Acute heart failure: vasoactive agents – does it matter?
Acta Medica Lituanica, 2012 Acute heart failure (AHF) is defined as the rapid onset of symptoms se condary to abnormal cardiac function. It is a syndrome and has a va riety of potential etiologies.
A. Macas, G. Zinkevičiūtė-Žarskienė
doaj +1 more source
Extended‐Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020 Background Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent form of heart failure, representing half of the total burden of heart failure. We hypothesised that modulation of the phosphodiesterase type 3/cyclic AMP using
Shane Nanayakkara +5 more
doaj +1 more source
Vasopressor stays vasopressor and inotrope stays inotrope! [PDF]
Critical Care, 2008 We should like to comment on the interesting work reported by Muller and colleagues [1]. We feel that the results of their experiment were predictable and that arginine vasopressin (AVP) was not indicated in that setting. Infusing a vasoconstrictor without relevant inotropic potential in an acute low flow state with maintained or increased vascular ...
Luckner, Günter +2 more
openaire +1 more source
JACC: Heart Failure, 2018 I have read with interest a recent meta-analysis by Nizamic et al. [(1)][1] of inotropes in heart failure. The authors concluded that inotropes improve functional status but do not impact survival.
openaire +2 more sources
Levosimendan for sepsis-induced myocardial dysfunction: friend or foe?
Frontiers in Cardiovascular MedicineSepsis-induced myocardial dysfunction (SIMD) involves reversible myocardial dysfunction. The use of inotropes can restore adequate cardiac output and tissue perfusion, but conventional inotropes, such as dobutamine and adrenaline, have limited efficacy ...
Xinxin Du +5 more
doaj +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background The utilization of mechanical circulatory support (MCS) in patients presenting with ST‐elevation myocardial infarction (STEMI) complicated by cardiogenic shock (CS) has increased substantially in recent years. However, it remains unclear whether the spectrum of MCS devices available and the type of hospital in which patients are ...
Mukunthan Murthi +5 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
The efficacy of hyperbaric oxygen therapy for skin perfusion following peripheral tissue injury due to usage of inotropes and vasopressors: a case report [PDF]
Clinical and Experimental Emergency MedicineHyperbaric oxygen therapy (HBOT) has garnered significant attention as a therapeutic modality with potential benefits across a variety of medical conditions, ranging from wound healing and ischemic conditions to neurologic disorders and radiation-induced
Nien Hsiu Suen +4 more
doaj +1 more source